Protective efficacy of neutralizing antibodies against Ebola virus infection
- 10 October 2006
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 25 (6), 993-999
- https://doi.org/10.1016/j.vaccine.2006.09.076
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Antibody-Dependent Enhancement of Ebola Virus InfectionJournal of Virology, 2003
- Identification of Protective Epitopes on Ebola Virus Glycoprotein at the Single Amino Acid Level by Using Recombinant Vesicular Stomatitis VirusesJournal of Virology, 2003
- Passive Transfer of Antibodies Protects Immunocompetent and Immunodeficient Mice against Lethal Ebola Virus Infection without Complete Inhibition of Viral ReplicationJournal of Virology, 2001
- Infectivity-Enhancing Antibodies to Ebola Virus GlycoproteinJournal of Virology, 2001
- Epitopes Involved in Antibody-Mediated Protection from Ebola VirusScience, 2000
- Evaluation of Immune Globulin and Recombinant Interferon‐α2b for Treatment of Experimental Ebola Virus InfectionsThe Journal of Infectious Diseases, 1999
- Preparation and Use of Hyperimmune Serum for Prophylaxis and Therapy of Ebola Virus InfectionsThe Journal of Infectious Diseases, 1999
- A system for functional analysis of Ebola virus glycoproteinProceedings of the National Academy of Sciences, 1997
- The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing.Proceedings of the National Academy of Sciences, 1996
- GP mRNA of Ebola Virus Is Edited by the Ebola Virus Polymerase and by T7 and Vaccinia Virus Polymerases1Virology, 1995